The FDA has designated Otulfi (ustekinumab-aauz) as an interchangeable biosimilar to the reference product Stelara (ustekinumab).

House Republicans have proposed cuts to Medicaid funding, which could be devastating to America’s rural hospitals.

The FDA has announced that it is taking steps to remove concentrated ingestible fluoride prescription drug products for children from the market.

In adults with nonalcoholic fatty liver disease and obesity, the estimated glucose disposal rate strongly negatively correlated with liver fibrosis severity.

Sarcopenia in the United States appears to be correlated to gallstone risk, most significantly among women, according to study results published in BMC Gastroenterology.

A new report says rice sold in US stores contains toxic heavy metals, including arsenic, cadmium, lead, and mercury.

Obesity did not significantly impact colonic endoscopic submucosal dissection results, but overtubes were used more for right ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Autoantibodies positivity was associated with a shorter time to diabetes development among children with acute and chronic pancreatitis.

OpenAI has unveiled a large dataset to help test how well artificial intelligence models answer health care questions.

Dupixent (dupilumab) Interleukin-4 receptor alpha antagonist Treatment of patients aged 12 years and older with chronic spontaneous urticaria who remain symptomatic despite H1 antihistamine treatment.

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.